- 1201. 224Ra
- [A short-lived, alpha-emitting isotope found in ground water and soils, Radium-224 has been used in biomedical treatments. Radium-224 in drinking water is a potential health risk due to its carcinogenic effects. In the first days after intake, radium heavily concentrates in endosteal bone. Because of the 3.5-day half-life, most Ra-224 decays while on bone surfaces, possibly inducing sarcomas in cells within range of the emitted alpha particles. (NCI04) ( NCI )] (UMLS (NCI) C0076535) =Pharmacologic Substance; Element, Ion, or Isotope ;
| - 1251. 27i
- [Mandibular right canine implant ( HL7V3.0 )] (UMLS (HL7) C1552197) =Medical Device =Artificial dentition;
|
- 1202. 22a
- [Mandibular left canine abutment ( HL7V3.0 )] (UMLS (HL7) C1553660) =Medical Device =Artificial dentition;
| - 1252. 27p
- [Mandibular right canine prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553616) =Medical Device =Artificial dentition;
|
- 1203. 22i
- [Mandibular left canine implant ( HL7V3.0 )] (UMLS (HL7) C1552192) =Medical Device =Artificial dentition;
| - 1253. 27pd
- [Mandibular right canine distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553617) =Medical Device =Artificial dentition;
|
- 1204. 22p
- [Mandibular left canine prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553601) =Medical Device =Artificial dentition;
| - 1254. 27pm
- [Mandibular right canine mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553615) =Medical Device =Artificial dentition;
|
- 1205. 22pd
- [Mandibular left canine distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553600) =Medical Device =Artificial dentition;
| - 1255. 27s
- [Supernumerary mandibular right canine ( HL7V3.0 )] (UMLS (HL7) C1552141) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
|
- 1206. 22pm
- [Mandibular left canine mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553602) =Medical Device =Artificial dentition;
| - 1256. 28
- [Mandibular right first premolar ( HL7V3.0 )] (UMLS (HL7) C0227069) tooth 28 =Body Part, Organ, or Organ Component =Permanent dentition;
|
- 1207. 22s
- [Supernumerary mandibular left canine ( HL7V3.0 )] (UMLS (HL7) C1552136) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
| - 1257. 28 kDa Heat Shock Protein
- [Heat-shock proteins belong to a large group stress proteins, induced in response to environmental challenges and developmental transitions. Involved in stress resistance and actin organization, synthesis of HSP27 is correlated with the acquisition of thermotolerance. HSP27 belongs to the HSP20 family and shows sequence similarity to alpha-crystallins. Cytoplasmic HSP27 associates with alpha- and beta-tubulin, and with interphase and mitotic microtubules. HSP27 translocates to the nucleus during heat shock and is phosphorylated on exposure to PKC activators and heat shock. (from OMIM 602195, Swiss-Prot P04792, and NCI) ( NCI )] (UMLS (NCI) C1447061) Estrogen-regulated 24 kDa Protein;
Heat Shock 27 kD Protein 1;
Heat Shock Protein 27;
HSPB1;
Stress-responsive Protein 27;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 1208. 23
- [Mandibular left lateral incisor ( HL7V3.0 )] (UMLS (HL7) C0227062) tooth 23 =Body Part, Organ, or Organ Component =Permanent dentition;
| - 1258. 28a
- [Mandibular right first premolar abutment ( HL7V3.0 )] (UMLS (HL7) C1553666) =Medical Device =Artificial dentition;
|
- 1209. 23-L-Leucinecolony-Stimulating Factor 2
- [A colony-stimulating factor that stimulates the production of white blood cells, especially granulocytes and macrophages, and cells (in the bone marrow) that are precursors of platelets. It is a cytokine that belongs to the family of drugs called hematopoietic (blood-forming) agents. Also called granulocyte-macrophage colony-stimulating factor (GM-CSF). ( NCI )] (UMLS (NCI) C0216231) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=Colony-Stimulating Factor, Granulocyte-Macrophage;
[BL400] BLOOD FORMATION PRODUCTS =sargramostim 0.5 MG/ML;
SARGRAMOSTIM 500 MCG;
SARGRAMOSTIM 250 MCG | - 1259. 28i
- [Mandibular right first premolar implant ( HL7V3.0 )] (UMLS (HL7) C1552198) =Medical Device =Artificial dentition;
|
- 1210. 239PU
- [An artificial radioactive element with long half-life, Plutonium-239 is produced by bombarding uranium-238 with slow neutrons and is used as the explosive in nuclear weapons and as fuel for nuclear reactors. Similar to uranium, Plutonium-239 is a heavy, fissionable metal that accumulates in bones upon exposure and presents health hazards. Plutonium oxidation results in stable, easily inhaled, particulate plutonium dioxide that represents a respiratory health hazard. Plutonium ingestion is considerably less dangerous since little is absorbed in the digestive system. (NCI04) ( NCI )] (UMLS (NCI) C0303580) =Element, Ion, or Isotope ;
| - 1260. 28p
- [Mandibular right first premolar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553619) =Medical Device =Artificial dentition;
|
- 1211. 23a
- [Mandibular left lateral incisor abutment ( HL7V3.0 )] (UMLS (HL7) C1553661) =Medical Device =Artificial dentition;
| - 1261. 28pd
- [Mandibular right first premolar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553620) =Medical Device =Artificial dentition;
|
- 1212. 23i
- [Mandibular left lateral incisor implant ( HL7V3.0 )] (UMLS (HL7) C1552193) =Medical Device =Artificial dentition;
| - 1262. 28pm
- [Mandibular right first premolar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553618) =Medical Device =Artificial dentition;
|
- 1213. 23p
- [Mandibular left lateral incisor prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553604) =Medical Device =Artificial dentition;
| - 1263. 28s
- [Supernumerary mandibular right first premolar ( HL7V3.0 )] (UMLS (HL7) C1552142) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
|
- 1214. 23pd
- [Mandibular left lateral incisor distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553603) =Medical Device =Artificial dentition;
| - 1264. 28S Ribosomal RNA
- [The largest of the three RNA components of the mammalian ribosome. ( NCI )] (UMLS (NCI) C0035705) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance
|
- 1215. 23pm
- [Mandibular left lateral incisor mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553605) =Medical Device =Artificial dentition;
| - 1265. 29
- [Mandibular right second premolar ( HL7V3.0 )] (UMLS (HL7) C0227070) tooth 29 =Body Part, Organ, or Organ Component =Permanent dentition;
|
- 1216. 23s
- [Supernumerary mandibular left lateral incisor ( HL7V3.0 )] (UMLS (HL7) C1552137) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
| - 1266. 29-30 COMP WKS GESTATION
- [ ] (UMLS (ICD9CM) C1135244) 29-30 completed weeks of gestation;
=Temporal Concept |
- 1217. 24
- [Mandibular left central incisor ( HL7V3.0 )] (UMLS (HL7) C0227064) tooth 24 =Body Part, Organ, or Organ Component =Permanent dentition;
| - 1267. 29-L-Argininamide-30-de-L-glutamine-31-de-L-glutamine-32-deglycine-33-de-L-glutamic acid-34-de-L-serine-35-de-L-asparagine-36-de-L-glutamine-37-de-L-glutamic acid-38-de-L-arginine-39-deglycine-40-de-L-alanine-41-de-L-arginine-42-de-L-alanine-43-de-L-argin
- [The acetate salt form of sermorelin, a synthetic, amidated 29-amino acid peptide that corresponds to the amino-terminal segment of the naturally occurring human growth hormone-releasing hormone (GHRH). Sermorelin acetate directly stimulates the pituitary gland, resulting in release of growth hormone leading to increased plasma growth hormone, which is responsible for many biological processes and counteracts growth hormone deficiency. ( NCI )] (UMLS (NCI) C0162725) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=GHRH;
=SERMORELIN ACETATE 50 MCG;
SERMORELIN ACETATE 1 MG;
SERMORELIN ACETATE 0.5 MG |
- 1218. 24 COMP WEEKS GESTATION
- [ ] (UMLS (ICD9CM) C0730522) 24 completed weeks of gestation =Finding
| - 1268. 29a
- [Mandibular right second premolar abutment ( HL7V3.0 )] (UMLS (HL7) C1553667) =Medical Device =Artificial dentition;
|
- 1219. 24 Hour Extended Release Suspension
- (UMLS (HL7) C1337572) 24 Hour Extended-Release Suspension;
=Biomedical or Dental Material; ;
=Extended Release Suspension;
| - 1269. 29i
- [Mandibular right second premolar implant ( HL7V3.0 )] (UMLS (HL7) C1552199) =Medical Device =Artificial dentition;
|
- 1220. 24 hours
- (UMLS (HL7) C0439584) =Temporal Concept =Duration categories;
| - 1270. 29p
- [Mandibular right second premolar prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553622) =Medical Device =Artificial dentition;
|
- 1221. 24 hours post challenge
- (UMLS (HL7) C1547070) =Temporal Concept =Time delay post challenge;
| - 1271. 29pd
- [Mandibular right second premolar distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553623) =Medical Device =Artificial dentition;
|
- 1222. 24a
- [Mandibular left central incisor abutment ( HL7V3.0 )] (UMLS (HL7) C1553662) =Medical Device =Artificial dentition;
| - 1272. 29pm
- [Mandibular right second premolar mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553621) =Medical Device =Artificial dentition;
|
- 1223. 24i
- [Mandibular left central incisor implant ( HL7V3.0 )] (UMLS (HL7) C1552194) =Medical Device =Artificial dentition;
| - 1273. 29s
- [Supernumerary mandibular right second premolar ( HL7V3.0 )] (UMLS (HL7) C1552143) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
|
- 1224. 24p
- [Mandibular left central incisor prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553607) =Medical Device =Artificial dentition;
| - 1274. 2a
- [Maxillary right second molar abutment ( HL7V3.0 )] (UMLS (HL7) C1553634) =Medical Device =Artificial dentition;
|
- 1225. 24pd
- [Mandibular left central incisor distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553606) =Medical Device =Artificial dentition;
| - 1275. 2alpha,3beta,23-Trihydroxyurs-12-en-28-oic Acid
- (UMLS (NCI) C0081660) =Organic Chemical; Pharmacologic Substance ;
|
- 1226. 24pm
- [Mandibular left central incisor mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553608) =Medical Device =Artificial dentition;
| - 1276. 2alpha,3beta,6beta,23-Tetrahydroxyurs-12-en-28-oic Acid
- (UMLS (NCI) C0065501) =Organic Chemical; Pharmacologic Substance ;
|
- 1227. 24s
- [Supernumerary mandibular left central incisor ( HL7V3.0 )] (UMLS (HL7) C1552138) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
| - 1277. 2B1
- [A monoclonal antibody with potential antineoplastic activity. Specific for both the immunoglobulin G (IgG) receptor CD16 and c-erbB-2, bispecific antibody 2B1 may enhance cellular immune responses against c-erbB-2-positive cells, resulting in increased tumor cell lysis. (NCI04) ( NCI )] (UMLS (NCI) C0338223) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 1228. 25
- [Mandibular right central incisor ( HL7V3.0 )] (UMLS (HL7) C0227065) tooth 25 =Body Part, Organ, or Organ Component =Permanent dentition;
| - 1278. 2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-diol Diacetate Dimethobromide
- [The bromide salt form of pancuronium, a synthetic, long-acting ammonio steroid muscle relaxant with curarimimetic, some antimuscarinic and sympathomimetic effects. Pancuronium bromide competitively binds to the nicotinic receptor at the neuromuscular junction, thereby preventing acetylcholine binding and resulting in skeletal muscle relaxation and paralysis. ( NCI )] (UMLS (NCI) C0030311) =Steroid; Pharmacologic Substance ;
=PANCURONIUM;
=PANCURONIUM BROMIDE 1 MG/ML;
PANCURONIUM BROMIDE 2 MG/ML |
- 1229. 25 minutes post challenge
- (UMLS (HL7) C1547071) =Temporal Concept =Time delay post challenge;
| - 1279. 2C4
- [A humanized recombinant monoclonal antibody directed against the extracellular dimerization domain of the HER-2 tyrosine kinase receptor. Binding of the antibody to the dimerization domain of the HER-2 tyrosine kinase receptor protein directly inhibits the ability of the HER-2 tyrosine kinase receptor protein (the most common pairing partner) to dimerize with other HER tyrosine kinase receptor proteins; inhibiting receptor protein dimerization prevents the activation of HER signaling pathways, resulting in tumor cell apoptosis. (NCI04) ( NCI )] (UMLS (NCI) C1328025) 2C4 Antibody;
MoAb 2C4;
Monoclonal Antibody 2C4;
Pertuzumab;
rhuMAb2C4 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor |
- 1230. 25-26 COMP WKS GESTATION
- [ ] (UMLS (ICD9CM) C1135242) 25-26 completed weeks of gestation;
=Temporal Concept | - 1280. 2CDA
- [An anticancer drug that belongs to the family of drugs called antimetabolites. ( NCI )] (UMLS (NCI) C0092801) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =2-Chloroadenosine;
[AN300] ANTINEOPLASTICS, ANTIMETABOLITES;
[AN000] ANTINEOPLASTICS;
Deoxyadenosines;
[IM600] IMMUNE SUPPRESSANTS;
deoxyadenosine =CLADRIBINE 1 MG/ML;
|
- 1231. 254-S
- (UMLS (NCI) C0950714) =Organic Chemical; Pharmacologic Substance
| - 1281. 2F1
- [Encoded by human SLC25A5 Gene (Mitochondrial Carrier Family), 298-aa 33-kDa homodimeric integral membrane protein Adenine Nucleotide Translocator-2 contains 3 Solcar repeats and catalyzes ADP/ATP exchange of across the inner mitochondrial membrane. ANT2 facilitates ADP/ATP exchange between the cytosol and mitochondria. The mitochondrial permeability transition pore (mtPTP) complex, which includes ANT, mediates sudden increase in inner mitochondrial membrane permeability common in apoptosis. ( NCI )] (UMLS (NCI) C1442882) Adenine Nucleotide Translocator-2;
ADP-ATP Translocase-2;
Fibroblast Adenine Nucleotide Translocator-2;
Fibroblast ADP-ATP Carrier Protein;
Mitochondrial Adenine Nucleotide Translocator Solute Carrier Family 25 Member-5;
Solute Carrier Family 25 Member-5;
T2;
T3;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 1232. 256U87
- [ ] (UMLS (CSP) C0249452) =Organic Chemical; Pharmacologic Substance ;
| - 1282. 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-Dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-Dioxide
- [A thiazide diuretic. Bendroflumethiazide directly inhibits sodium and chloride reabsorption on the luminal membrane of the early segment of the distal convoluted tubule in the kidney. This drug increases water, sodium, chloride, potassium and bicarbonate excretion and decreases calcium and uric acid secretion. Bendroflumethiazide is commonly used to treat hypertension, edema, and congestive heart failure. ( NCI )] (UMLS (NCI) C0004975) =Organic Chemical; Pharmacologic Substance
|
- 1233. 25a
- [Mandibular right central incisor abutment ( HL7V3.0 )] (UMLS (HL7) C1553663) =Medical Device =Artificial dentition;
| - 1283. 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-(trifluoromethyl)-, 1,1-Dioxide
- [A thiazide diuretic with antihypertensive activity. Hydroflumethiazide directly inhibits sodium and chloride reabsorption on the luminal membrane of the early segment of the distal convoluted tubule in the kidney. This results in an increase in water, sodium, chloride, potassium and bicarbonate excretion and a decrease in calcium and uric acid secretion. (NCI05) ( NCI )] (UMLS (NCI) C0020273) =Organic Chemical; Pharmacologic Substance ;
=benzothiadiazine;
[CV701] THIAZIDES/RELATED DIURETICS =HYDROFLUMETHIAZIDE 50 MG |
- 1234. 25i
- [Mandibular right central incisor implant ( HL7V3.0 )] (UMLS (HL7) C1552195) =Medical Device =Artificial dentition;
| - 1284. 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-(((2,2,2-trifluoroethyl)thio)methyl)-, 1,1-Dioxide
- [A sulfonamide derivative and a synthetic thiazide with diuretic, antihypertensive and anti-urolithic properties. By blocking the Na/Cl transporter, polythiazide inhibits reabsorption of sodium and chloride in the proximal and distal convoluted tubule of the kidney, resulting in increased excretion of water and electrolytes (sodium, potassium, chloride, magnesium, and bicarbonate) and subsequent reversal of hypertension. In addition, this agent exerts its anti-urolithic effect by decreasing calcium and uric acid excretion. ( NCI )] (UMLS (NCI) C0032613) =Organic Chemical; Pharmacologic Substance ;
=benzothiadiazine;
[CV701] THIAZIDES/RELATED DIURETICS =POLYTHIAZIDE 0.5 MG;
POLYTHIAZIDE 1 MG;
POLYTHIAZIDE 2 MG;
POLYTHIAZIDE 4 MG;
|
- 1235. 25p
- [Mandibular right central incisor prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553610) =Medical Device =Artificial dentition;
| - 1285. 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-, 1,1-Dioxide
- [A thiazide diuretic with antihypertensive activity. Methyclothiazide directly inhibits sodium and chloride reabsorption on the luminal membrane of the early segment of the distal convoluted tubule in the kidney. This results in an increase in water, sodium, chloride, potassium and bicarbonate excretion and a decrease in calcium and uric acid secretion. ( NCI )] (UMLS (NCI) C0025696) =Organic Chemical; Pharmacologic Substance ;
=benzothiadiazine;
[CV701] THIAZIDES/RELATED DIURETICS =NIVEA SKIN OIL;
METHYCLOTHIAZIDE 2.5 MG;
METHYCLOTHIAZIDE 5 MG |
- 1236. 25pd
- [Mandibular right central incisor distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553611) =Medical Device =Artificial dentition;
| - 1286. 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-, 1,1-Dioxide
- [A thiazide diuretic with antihypertensive activity. Trichlormethiazide directly inhibits sodium and chloride reabsorption on the luminal membrane of the early segment in the distal convoluted tubule in the kidney. This leads to an increase in water, sodium, chloride, bicarbonate, and potassium secretion and a decrease in calcium and uric acid secretion. ( NCI )] (UMLS (NCI) C0040899) =Organic Chemical; Pharmacologic Substance =[CV701] THIAZIDES/RELATED DIURETICS;
6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide =TRICHLORMETHIAZIDE 4 MG |
- 1237. 25pm
- [Mandibular right central incisor mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553609) =Medical Device =Artificial dentition;
| - 1287. 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-
- [benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia. ( CSP )] (UMLS (NCI) C0029997) =Organic Chemical; Pharmacologic Substance ;
=benzodiazepine;
Benzodiazepinones;
tranquilizer;
[CN302] BENZODIAZEPINE DERIVATIVE, SEDATIVES/HYPNOTICS =OXAZEPAM 10 MG;
OXAZEPAM 15 MG;
OXAZEPAM 30 MG;
|
- 1238. 25s
- [Supernumerary mandibular right central incisor ( HL7V3.0 )] (UMLS (HL7) C1552139) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
| - 1288. 2H-1,4-Benzodiazepine-2-thione, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-
- [A synthetic benzodiazepine derivative with anxiolytic, sedative and hypnotic properties. Quazepam and its major metabolite 2-oxoquazepam potentiate gamma-aminobutyric acid (GABA) activity by binding to the benzodiazepine-1 recognition site (BZ-1) within the GABA-A receptor, located in the limbic, neocortical and mesencephalic reticular system. This increases the frequency of GABA-activated chloride channel opening events, allowing the flow of chloride ions into the neuron leading to membrane hyperpolarization and decreased neuronal excitability. ( NCI )] (UMLS (NCI) C0072828) =Organic Chemical; Pharmacologic Substance =[CN302] BENZODIAZEPINE DERIVATIVE, SEDATIVES/HYPNOTICS;
Unclassified Ingredients =QUAZEPAM 15 MG;
QUAZEPAM 7.5 MG;
|
- 1239. 26
- [Mandibular right lateral incisor ( HL7V3.0 )] (UMLS (HL7) C0227067) tooth 26 =Body Part, Organ, or Organ Component =Permanent dentition;
| - 1289. 2H-1-Benzopyran-2-one
- [oxygen containing heterocyclic compound, obtainable naturally from several plants, or produced synthetically from an amino acid of phenylalanine; it is used for the preparation of drugs especially anticoagulants such as bishydroxycoumarin (dicoumarol) and warfarin (coumadin); coumarin glycosides such as dicoumarol and warfarin, are widely used as rodenticides. ( CSP )] (UMLS (NCI) C0010206) =Organic Chemical; Pharmacologic Substance =pyrone;
=furocoumarin;
1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone;
|
- 1240. 26a
- [Mandibular right lateral incisor abutment ( HL7V3.0 )] (UMLS (HL7) C1553664) =Medical Device =Artificial dentition;
| - 1290. 2H-10,4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, Tartrate
- [The tartrate salt form of levorphanol, a synthetic phenanthrene with potent opioid analgesic activity. Levorphanol tartrate mimics the actions of endogenous peptides at CNS opioid receptors, thereby producing the characteristic morphine-like effects on the mu-opioid receptor, including analgesia, euphoria, sedation, respiratory depression, miosis, bradycardia and physical dependence. ( NCI )] (UMLS (NCI) C0596008) =Organic Chemical; Pharmacologic Substance =LEVORPHANOL;
=LEVORPHANOL TARTRATE 2 MG;
LEVORPHANOL TARTRATE 2 MG/ML |
- 1241. 26i
- [Mandibular right lateral incisor implant ( HL7V3.0 )] (UMLS (HL7) C1552196) =Medical Device =Artificial dentition;
| - 1291. 2H-Benzimidazol-2-one, 1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-
- [diphenylbutylpiperidine that is used as an antipsychotic agent and as an alternative to haloperidol for the suppression of vocal and motor tics in patients with Tourette syndrome. ( CSP )] (UMLS (NCI) C0031935) =Organic Chemical; Pharmacologic Substance =benzimidazole;
[CN700] ANTIPSYCHOTICS;
[CN900] CNS MEDICATIONS, OTHER;
=PIMOZIDE 2 MG;
PIMOZIDE 1 MG;
|
- 1242. 26p
- [Mandibular right lateral incisor prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553613) =Medical Device =Artificial dentition;
| - 1292. 2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-
- [A benzothiazolylpiperazine derivative and an atypical antipsychotic agent with an antischizophrenic property. Ziprasidone functions as an antagonist at the dopamine D2 and serotonin 5-HT2A and 5-HT1D receptors, and as an agonist at the 5-HT1A receptor. Ziprasidone also inhibits the synaptic reuptake of serotonin and norepinephrine. The mechanism of action by which ziprasidone exerts its antischizophrenic effect is unknown but is potentially mediated through a combination of dopamine D2 and serotonin 5-HT2 antagonism. This agent also has antagonistic activity against histamine H1 and alpha-1-adrenergic receptors. ( NCI )] (UMLS (NCI) C0380393) =Organic Chemical; Pharmacologic Substance ;
=Piperazines;
thiazole;
[CN709] ANTIPSYCHOTICS, OTHER;
=ZIPRASIDONE 20 MG;
ZIPRASIDONE 40 MG;
ZIPRASIDONE 60 MG;
ZIPRASIDONE 80 MG |
- 1243. 26pd
- [Mandibular right lateral incisor distal prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553614) =Medical Device =Artificial dentition;
| - 1293. 2H-pyran-2-one,5,6-dihydro-6-(3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11,-tridecatetraenyl)-,trans
- [An anti-tumor antibiotic isolated from the bacterium Streptomyces pulveraceus. Fostriecin inhibits topoisomerase II catalytic activity, resulting in protein-associated strand breaks and impaired DNA and RNA synthesis in various malignant cell types. This agent also inhibits serine/threonine protein phosphatase type 2A in some tumor cell types, thereby interfering with cellular proliferation and differentiation. (NCI04) ( NCI )] (UMLS (NCI) C0118175) =Organic Chemical; Pharmacologic Substance
|
- 1244. 26pm
- [Mandibular right lateral incisor mesial prosthesis ( HL7V3.0 )] (UMLS (HL7) C1553612) =Medical Device =Artificial dentition;
| - 1294. 2i
- [Maxillary right second molar implant ( HL7V3.0 )] (UMLS (HL7) C1552166) =Medical Device =Artificial dentition;
|
- 1245. 26s
- [Supernumerary mandibular right lateral incisor ( HL7V3.0 )] (UMLS (HL7) C1552140) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
| - 1295. 2ND DEG BURN ABDOMN WALL
- [ ] (UMLS (ICD9CM) C0840804) Blisters with epidermal loss due to burn [second degree] of abdominal wall =Injury or Poisoning
|
- 1246. 26S ATP-Dependent Protease
- [Proteasomes are large multicatalytic proteolytic complexes found in all eukaryotic cells, and simpler forms have been found in archaebacteria and certain eubacteria. In eukaryotes, the 20S proteasome also exists as the central core of the 26S (2000 kDa) proteasome complex, which catalyzes the degradation of ubiquitin-conjugated proteins and contains an additional 19S complex, composed of regulatory proteins and six ATPases. ( NCI )] (UMLS (NCI) C0286330) =Amino Acid, Peptide, or Protein; Enzyme
| - 1296. 2ND DEG BURN ANKLE
- [ ] (UMLS (ICD9CM) C0161283) =Injury or Poisoning
|
- 1247. 26S Proteasome Regulatory Subunit p28
- [The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. This protein is a non-ATPase subunit of the 19S regulator. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. (from LocusLink) ( NCI )] (UMLS (NCI) C0911800) Gankyrin;
Hepatocellular Carcinoma-Associated Protein p28-II;
Proteasome 26S Subunit Non-ATPase 10;
PSMD10 =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 1297. 2ND DEG BURN ARM NOS
- [ ] (UMLS (ICD9CM) C0161166) =Injury or Poisoning
|
- 1248. 27
- [Mandibular right canine ( HL7V3.0 )] (UMLS (HL7) C0227068) tooth 27 =Body Part, Organ, or Organ Component =Permanent dentition;
| - 1298. 2ND DEG BURN ARM-MULT
- [ ] (UMLS (ICD9CM) C0161173) =Injury or Poisoning
|
- 1249. 27-28 COMP WKS GESTATION
- [ ] (UMLS (ICD9CM) C1135243) 27-28 completed weeks of gestation;
=Temporal Concept | - 1299. 2ND DEG BURN AXILLA
- [ ] (UMLS (ICD9CM) C0161170) =Injury or Poisoning
|
- 1250. 27a
- [Mandibular right canine abutment ( HL7V3.0 )] (UMLS (HL7) C1553665) =Medical Device =Artificial dentition;
| - 1300. 2ND DEG BURN BACK
- [ ] (UMLS (ICD9CM) C0840805) Blisters with epidermal loss due to burn [second degree] of back [any part] =Injury or Poisoning
|
home
